Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04575961
Title Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer (PERCEPTION)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors North Eastern German Society of Gynaecological Oncology

ovarian serous carcinoma

fallopian tube cancer

peritoneum cancer


Carboplatin + Pegylated liposomal-doxorubicin + Pembrolizumab

Carboplatin + Gemcitabine + Pembrolizumab

Age Groups: senior | adult
Covered Countries DEU

No variant requirements are available.